Press releases

Advanced Search
  • Jan 27, 2022
    Company Included in 2022 Bloomberg Gender-Equality Index and Named Best Place to Work for LGBTQ+ Equality from The Human Rights Campaign Foundation

    BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has been included in the 2022 Bloomberg Gender-Equality Index (GEI) for the...

  • Jan 26, 2022
    Study uses real-world data to demonstrate the effectiveness of vaginal panel performed on the BD MAX™ System compared to clinicians' assessments

    BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the outcome of a peer-reviewed study published in the journal of Obstetrics &...

  • Jan 25, 2022

    The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.87 per common share, payable on March 31, 2022 to holders of record on March 10,...

  • Jan 20, 2022
    Technology Breakthrough Has Potential to Transform Wide Range of Disciplines from Immunology and Genomics Research to Cell-Based Therapeutics

    BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that a study conducted in collaboration with the European Molecular Biology Laboratory...

  • Jan 11, 2022
    JUST 100, the Only Ranking that Recognizes Companies Doing Right by All Their Stakeholders as Defined by the American Public, Acknowledges BD's Commitment to Environmental, Social and Governance Performance

    BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it was named to the JUST 100 list of America's most just companies by JUST Capital and...

Show 5102550100 per page